Pavaki Capital Management LLC

Position in PFE — Pfizer Inc

CIK 2143027

Position in PFE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$298,592

-$49,600 QoQ

Shares Held

12,400

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#2,135

of 2,821 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pavaki Capital Management LLC holds $2,766,232 across 5 Drug Manufacturers - General names. PFE ranks #4 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SNY	Sanofi	20,000	$853,200
2	BIIB	Biogen Inc.	3,500	$756,210
3	MRK	Merck & Co., Inc.	5,000	$642,500
4	PFE	Pfizer Inc This page	12,400	$298,592
5	NVO	Novo Nordisk A S	4,500	$215,730

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$298,592	12,400	0.0%	Shares	Sole	2026-08-07
2026-03-31	$348,192	12,400	0.0%	Shares	Sole	2026-08-07
2025-12-31	$308,760	12,400	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.